Preventing fainting in first-time blood donors
Part of Brain & nervous system clinical trials.
This trial tests a combined psychological and physical approach to prevent fainting or lightheadedness in people donating blood for the first time. If you are a first-time donor, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- This is your first time donating blood
- You weigh at least 50 kg and are at least 135 cm tall
- You can be reached by phone about a week after donating
- You are not allergic to shellfish, gluten, milk, or soy
- You speak and understand French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart ultrasound (echocardiography) to see how the heart changes when healthy volunteers donate blood. If you're a healthy adult who can donate blood, you may help researchers understand more about blood donation's effect on the heart.
This study looks at how storing whole blood from group O donors affects blood cells and inflammation. It may help improve blood transfusions for patients.
This trial studies people who donate blood and checks what happens in your body after donation, focusing on safety and measurements in lab tests. You may be able to join if you are healthy and pass screening labs and health history checks.
This trial is studying heart and blood circulation problems that may happen during a certain type of organ donation (called Maastricht 3). It is for people who donate organs and those who receive them. The goal is to see how the level of oxygen in the blood affects these problems.
This study tests whether teaching special standing/balance movements can reduce fainting episodes in children who have recurring vasovagal fainting or certain forms of POTS. It may help your child feel more stable when standing and improve symptoms, while researchers measure balance and “counterpressure” responses during the tests.
This early (Phase 1) study tests whether giving a growth factor injection (rhu-G-CSF) to healthy volunteers can help collect whole blood for research. It looks at safety and whether the donated blood can be collected under specific health conditions.
Hear when a new Vasovagal Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.